Media-OutReach Newswire Berlin Cures' BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Media-OutReach Newswire Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Media-OutReach Newswire Watsons Singapore Launches Tru Niagen® Immune, a Groundbreaking Formula for Age Transformation and Immunity Boost
Media-OutReach Newswire Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA
Media-OutReach Newswire Novel Chinese medicine for constipation developed by HKBU authorised by U.S. FDA for clinical trial
Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire HKU’s innovative research novelties excel at 48th International Exhibition of Inventions of Geneva
Media-OutReach Newswire Oscars 2023: raising the curtain on the recovery and risks in the entertainment industry